EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudie

Opportunistic Gastric Cancer Endoscopic Screening Integrated Into Population‐Based Colorectal Cancer Screening: A Retrospective Economic Cost‐Comparison Study

B Mourato iD, P Pinto iD, J Vieira iD, M Vidinha iD, V Carvalho, N Pratas iD, H Capote iD, I Fronteira iD, R Dinis iD, M Areia iD

Helicobacter · 2026-09 · 31 (5)

DOI: 10.1111/hel.70161 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Helicobacter, online erschienen am 04.10.2026. Verfasst von B Mourato und 9 weiteren Autor:innen. Beteiligte Einrichtung: NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, LA-REAL, CCAL, NOVA University Lisb…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Mass Screening, Stomach Neoplasms. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) remains a major cause of cancer‐related mortality worldwide, with prognosis and treatment costs strongly influenced by disease stage at diagnosis. Endoscopic GC screening has been proposed for intermediate‐to‐high‐risk countries, although its economic feasibility remains uncertain. This study evaluated the costs associated with opportunistic GC screening integrated into a colorectal cancer screening programme and compared modeled early‐stage management scenarios with the real‐world costs of managing Stages II–IV disease.

Methods

A retrospective cost‐comparison study was conducted from the perspective of the Portuguese National Health Service. Screening costs were derived from 377 fecal immunochemical testing‐positive individuals undergoing one‐time opportunistic esophagogastroduodenoscopy (EGD) during colonoscopy within the organized colorectal cancer screening programme, and treatment costs from a retrospective cohort of 222 patients with gastric adenocarcinoma. Direct medical costs were analyzed according to disease stage and compared with two modeled early‐stage management scenarios.

Results

Gastric precancerous conditions were identified in 46.9% of screened individuals, and gastric adenocarcinoma was detected in 0.8% (3/377). The estimated screening cost was €17,249 per cancer detected. Mean treatment and follow‐up costs per patient were €32,140 for Stage II disease, €33,073 for Stage III disease, and €19,287 for Stage IV disease. The estimated cumulative cost of screening followed by ESD was €27,624, whereas screening followed by surgical treatment of Stage I disease was estimated at €44,493.

Conclusions

GC management is associated with substantial healthcare expenditure. The potential economic value of opportunistic GC screening is likely to depend on the detection of lesions amenable to endoscopic treatment. Trail Registration NCT07522320.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEarly Detection of CancerMass ScreeningStomach NeoplasmsAgedFemaleHumansMaleMiddle AgedEndoscopy, Digestive SystemPortugalRetrospective Studies

Stichwörter der Autor:innen

economic evaluationendoscopic submucosal dissectionendoscopygastric cancerhealthcare costsscreening

Autor:innen und Institutionen

  • NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, LA-REAL, CCAL, NOVA University Lisbon, Lisbon, Portugal.
  • Unidade Local de Saúde Do Alto Alentejo, Hospital Doutor José Maria Grande, Portalegre, Portugal.
  • Unidade Local de Saúde Do Alto Alentejo, Hospital Doutor José Maria Grande Portalegre, Portalegre, Portugal.
  • Hospital Do Espírito Santo de Évora, Évora, Portugal.
  • Instituto Português de Oncologia de Coimbra, Coimbra, Portugal.
  • RISE@CI-IPO (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.

ORCID-Profile: B Mourato, P Pinto, J Vieira, M Vidinha, N Pratas, H Capote, I Fronteira, R Dinis, M Areia

Zitieren

APA

Mourato, B., Pinto, P., Vieira, J., Vidinha, M., Carvalho, V., Pratas, N., Capote, H., Fronteira, I., Dinis, R., & Areia, M. (2026). Opportunistic Gastric Cancer Endoscopic Screening Integrated Into Population‐Based Colorectal Cancer Screening: A Retrospective Economic Cost‐Comparison Study. Helicobacter, 31(5). https://doi.org/10.1111/hel.70161

Vancouver

Mourato B, Pinto P, Vieira J, Vidinha M, Carvalho V, Pratas N, et al. Opportunistic Gastric Cancer Endoscopic Screening Integrated Into Population‐Based Colorectal Cancer Screening: A Retrospective Economic Cost‐Comparison Study. Helicobacter. 2026;31(5). doi:10.1111/hel.70161

BibTeX
@article{Mourato2026,
  author = {Mourato, B and Pinto, P and Vieira, J and Vidinha, M and Carvalho, V and Pratas, N and Capote, H and Fronteira, I and Dinis, R and Areia, M},
  title = {Opportunistic Gastric Cancer Endoscopic Screening Integrated Into Population‐Based Colorectal Cancer Screening: A Retrospective Economic Cost‐Comparison Study},
  journal = {Helicobacter},
  year = {2026},
  volume = {31},
  number = {5},
  doi = {10.1111/hel.70161}
}
Kostenlos starten →